Each patient was assessed VTE risk by PADUA scale, bleeding risk by IMPROVE scale, and identified an appropriate prophylaxis strategy using American College of Chest Physicians (ACCP) guideline for Antithrombotic Therapy and Prevention of Thrombosis 9th edition (2012) at the admission time and reassessed every 7 days.